Dexamethasone Decreases contraction to electrical field stimulation in mesenteric arteries from spontaneously hypertensive rats through decreases in thromboxane A2 release

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 3, 2007, Pages 1129-1136

  Aras Lopéz, Rosa ^a   Blanco Rivero, Javier ^a   Xavier, Fabiano E ^b   Salaices, Mercedes ^a   Ferrer, Mercedes ^a   Balfagón, Gloria ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b DEPARTAMENTO DE MICOLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; FUREGRELATE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NORADRENALIN; PHENTOLAMINE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; ELECTROSTIMULATION; ESSENTIAL HYPERTENSION; HORMONAL REGULATION; INCUBATION TIME; MALE; MESENTERIC ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TIME; VASOMOTOR REFLEX; WESTERN BLOTTING; WISTAR KYOTO RAT;

EID: 34548102417     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.123596     Document Type: Article

References (31)

1. Adeagbo AS, Patel D, Iddrissu A, Walker J, Thirumalai S, Joshua IG, Schuschke D, and Wang Y (2003) NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: role of endothelium. Eur J Pharmacol 458:145-154.
2. Alvarez Y, Briones AM, Balfagon G, Alonso MJ, and Salaices M (2005) Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens 23:767-777.
3. Alvarez Y, Pérez-Girón JV, Hernanz R, Briones AM, García-Redondo A, Beltrán A, Alonso MJ, and Salaices M (2007) Losartan reduces the increased participation of Cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther 321:381-388.
4. Balfagón G, Marquez-Rodas I, Alvarez Y, Alonso MJ, Cachofeiro V, Salaices M, and Lahera V (2004) Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide. Regul Pept 120:253-260.
5. Blanco-Rivero J, Balfagón G, and Ferrer M (2006) Orchidectomy modulates alpha-2-adrenoceptor reactivity in rat mesenteric artery through increased thromboxane A2 formation. J Vasc Res 43:101-108.
6. Donoso MV, Steiner M, and Huidobro-Toro JP (1997) BIBP 3226, suranim and prazosin identify neuropeptide Y, adenosine 5-triphosphate and noradrenaline as sympathetic contransmitter in the rat arterial mesenteric bed. J Pharmacol Exp Ther 282:691-698.
7. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
8. Jun SS, Chen Z, Pace MC, and Shaul PW (1999) Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. Circ Res 84:193-200.
9. Kalavantavanich K and Schramm CM (2000) Dexamethasone potentiates high-affinity beta-agonist binding and g(s) alpha protein expression in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 278:L1101-L1106.
10. Kawasaki H, Takasaki K, Saito A, and Goto H (1988) Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335:164-167.
11. Koltai MZ, Rosen P, Ballagi-Pordany G, Hadhazy P, and Pogatsa G (1990) Increased vasoconstrictor response to noradrenaline in femoral vascular bed of diabetic dogs: is thromboxane A2 involved? Cardiovasc Res 24:707-710.
12. Laan RF, Jansen TL, and van Riel PL (1999) Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology 38:6-12.
13. Lenders JW, Golczynska A, and Goldstein DS (1995) Glucocorticoids, sympathetic activity, and presynaptic alpha 2-adrenoceptor function in humans. J Clin Endocrinol Metab 80:1804-1808.
14. Limbourg FP and Liao JK (2003) Nontranscriptional actions of the glucocorticoids receptor. J Mol Med 81:168-174.
15. Loesch A (2002) Perivascular nerves and vascular endothelium: recent advances. Histol Histopathol 17:591-597.
16. Marín J, Ferrer M, and Balfagón G (2000) Role of protein kinase C in electrical-stimulation-induced neuronal nitric oxide release in mesenteric arteries from hypertensive rats. Clin Sci 99:277-283.
17. Márquez-Rodas I, Longo F, Aras-López R, Blanco-Rivero J, Dieguez E, Tejerina T, Ferrer M, and Balfagon G (2006) Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats. Regul Pept 134:61-66.
18. Pipili E, Zoumboulis G, and Maragoudakis ME (1988) Prostaglandin I2 and thromboxane A2 production in relation to alpha 1 and alpha 2-adrenoreceptor activation in the normotensive and hypertensive rat. J Auton Pharmacol 8:333-342.
19. Ralevic V, Karoon P, and Burnstock G (1995) Long-term sensory denervation by neonatal capsaicin treatment augments sympathetic neurotransmission in rat mesenteric arteries by increasing levels of norepinephrine and selectively enhancing postjunctional action. J Pharmacol Exp Ther 274:64-71.
20. Sudhir K, Jennings GL, Esler MD, Korner PI, Blombery PA, Lambert GW, Scoggins B, and Whitworth JA (1989) Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension 13:416-421.
21. Supowit SC, Gururaj A, Ramana CV, Westlund KN, and DiPette DJ (1995) Enhanced neuronal expression of calcitonin gene-related peptide in mineralocorticoid-salt hypertension. Hypertension 25:1333-1338.
22. Tabernero A, Giraldo J, and Vila E (1999) Modeling the changes due the endothelium and hypertension in the α-adrenoreceptor-mediated response of the rat aorta. J Auton Pharmacol 19:219-228.
23. Ullian ME (1999) The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 41:55-64.
24. Vila JM, Martínez-León JB, Medina P, Segarra G, Ballester RM, Otero E, and Lluch S (2001) U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: antagonism by thromboxane receptor blockade. Cardiovasc Res 52:462-467.
25. Walker BR (2007) Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroids dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning. Proc Nutr Soc 66:1-8.
26. Watson RE, Supowit SC, Zhao H, Katki KA, and Dipette DJ (2002) Role of sensory nervous system vasoactive peptides in hypertension. Braz J Med Biol Res 35:1033-1045.
27. Whitworth JA, Brown MA, Kelly JJ, and Williamson PM (1995) Mechanisms of cortisol-induced hypertension in humans. Steroids 60:76-80.
28. Wimalawansa SJ (1996) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17:533-585.
29. Xavier FE, Davel AP, Rossoni LV, and Vassallo DV (2003) Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization. Vasc Pharmacol 40:67-76.
30. Yang S and Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2:1-12.
31. Zingarelli B, Caputi AP, and Di Rosa M (1994) Dexamethasone prevents vascular failure mediated by nitric oxide in hemorrhagic shock. Shock 2:210-215.